Primary Site >> Colorectal Cancer
Gene >> CD19
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Effects of radiolabelled monoclonal antibody infusion on blood leukocytes in cancer patients. PMID: 1968968 |
Ref: Changes in leucocyte populations following murine bifunctional antibody infusion in colon cancer patients. PMID: 2025955 |
Ref: Alteration in lymphocyte phenotype associated with administration of adjuvant levamisole and 5-fluorouracil. PMID: 7515770 |
Ref: Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions. PMID: 7624448 |
Ref: Lymphocyte subset infiltration patterns and HLA antigen status in colorectal carcinomas and adenomas. PMID: 8566865 Ref: DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis. PMID: 8609244 Ref: Necessity of biotherapeutic treatments inducing TH1 cell functions in colorectal cancer. PMID: 10851498 Ref: Immunological directives for biotherapy improvement in the treatment of colorectal cancer. PMID: 10851527 |
Ref: The sCEA molecule suppressive role in NK and TH1 cell functions in colorectal cancer. PMID: 10851473 Ref: Immunological implications of alterations in the c-Ki-ras and p53 genes in the stepwise progression of colorectal cancer: indications for the improvement of prognosis, biotherapy treatment and tumor biology understanding PMID: 10851492 |
Ref: Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver. PMID: 10228796 |
Ref: Changes in T cell subsets, interleukin-6 and C-reactive protein after laparoscopic and open colorectal resection for malignancy. PMID: 11727135 |
Ref: Cell surface phenotyping and cytokine production of Epstein-Barr Virus (EBV)-transformed lymphoblastoid cell lines (LCLs). PMID: 12191505 |
Ref: [Expression of leucocyte cell-surface antigens on colon cancer cell line HR8348]. PMID: 15067730 |
Ref: Significance of increased proliferation of immature plasma cells in the appendix of patients with ulcerative colitis. PMID: 15702231 |
Ref: CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes. PMID: 18684979 |
Ref: Perioperative cimetidine administration improves systematic immune response and tumor infiltrating lymphocytes in patients with colorectal cancer. PMID: 22944376 Ref: Impaired migration of IgA-secreting cells to colon adenocarcinomas. PMID: 23591979 Ref: [Changes of lymphocyte subsets before and after chemotherapy in colorectal carcinoma patients]. PMID: 23643003 Ref: Immunomodulatory effects in a phase II study of lenalidomide combined with cetuximab in refractory KRAS-mutant metastatic colorectal cancer patients. PMID: 24244687 |
Ref: Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. PMID: 27086589 |
Ref: Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation. PMID: 28558303 Ref: MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis. PMID: 28686677 |
Ref: Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer. PMID: 29342159 Ref: miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy. PMID: 29685162 Ref: Immune Condition of Colorectal Cancer Patients Featured by Serum Chemokines and Gene Expressions of CD4+ Cells in Blood. PMID: 29992127 |